BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Vivascience AG Offers Increased Adenovirus Recovery For Same Price


10/19/2005 5:10:34 PM

HANOVER, Germany--(BUSINESS WIRE)--May 3, 2005-- The upgraded Vivapure(R) AdenoPACK(TM) 100 achieves unprecedented fast, efficient and also economical Adenovirus purification Vivascience, a subsidiary of Sartorius AG, introduces an upgraded version of the Vivapure AdenoPACK 100, a ready to use kit for adenovirus purification, to the market. Vivapure AdenoPACK 100 has been successfully launched in the beginning of 2005. In order to increase the customer benefit even further against traditional CsCl gradients, the virus binding capacity of the AdenoPACK 100 units has been increased 2-fold. Now up to 1 x 10 E13 virus particles can be purified from 200 ml cell culture, for the same price as before.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES